↗3 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$474KSold on the market
1Companies
Oct 5, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 202617:12 | Oct 5, 2026 | RPRXRoyalty Pharma plc | EVP, Research & Investments | S · Sell10b5-1 | $57.10 | −4,126 | 0 | -100% | −$236K | ||
| Sep 30, 202616:32 | Sep 28, 2026 | RPRXRoyalty Pharma plc | EVP, Research & Investments | S · Sell10b5-1 | $57.88 | −4,126 | 4,126 | -50% | −$239K | ||
| Aug 7, 202617:11 | Aug 5, 2026 | RPRXRoyalty Pharma plc | EVP, Research & Investments | A · Grant | — | +8,252 | 8,252 | New | — |